Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in brand-name Wegovy, triggers weight loss by slowing stomach emptying and reducing hunger signals in the brain. Most patients notice their first measurable results within four weeks, though the pace of loss depends on your body's unique response to the medication.
Realistic First-Month Weight Loss Timeline
Clinical trials show that patients on semaglutide typically lose between 1 and 5 pounds in their first month of treatment. This initial phase establishes a baseline and allows your body to adapt to the medication's effects. The variation in early weight loss reflects differences in starting weight, baseline metabolism, and how quickly your body responds to GLP-1 receptor activation.
Your first dose is intentionally low—usually 0.25 milligrams—to minimize side effects and allow your system to adjust. Because the dose is modest at this stage, dramatic weight loss during month one is uncommon. Many patients find that more significant fat loss accelerates during months two through four, once doses are increased under medical supervision.
How Semaglutide Creates Weight Loss in Your Body
Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a natural hormone that regulates appetite and blood sugar. When you take semaglutide, it binds to GLP-1 receptors in your brain's appetite centers, sending signals of fullness earlier in meals. This mechanism reduces your calorie intake without requiring willpower-based restriction, making sustainable weight loss more achievable.
Beyond appetite suppression, semaglutide also slows gastric emptying—the rate at which food leaves your stomach. This delayed emptying keeps you feeling satisfied longer and stabilizes blood sugar swings that often trigger cravings. These combined effects explain why month-one weight loss is steady but often modest; your body is establishing new hunger patterns rather than entering a dramatic calorie deficit.
Factors That Influence Your First-Month Results
Your starting weight significantly affects early weight loss numbers. Individuals who weigh more tend to lose more pounds in absolute terms during the first month, though percentage-based loss is typically similar across weight categories. Your baseline metabolism, age, physical activity level, and diet quality all contribute to how quickly your body sheds fat once GLP-1 signaling is activated.
Genetics also play a meaningful role in how your body responds to semaglutide. The PlexusDx Precision Peptide Genetic Test analyzes key variants in your GLP1R, GIPR, FTO, and MC4R genes—revealing your inherited predispositions for GLP-1 responsiveness. Understanding these pathways helps your provider personalize your treatment approach, potentially optimizing your weight loss trajectory from month one forward.
What to Expect Beyond the First Month
Most patients experience accelerated weight loss from month two through month four, once their dose reaches therapeutic levels. Trial data shows that cumulative weight loss over 16 weeks averages 8 to 15 pounds, depending on the starting dose schedule and individual factors. By month six, patients typically report 10 to 20 pounds of total weight loss, with the rate of loss often plateauing as your body adapts.
PlexusDx offers compounded semaglutide injections starting at $149 per month—the same flat price regardless of your dose level, because your dose may need to go up but your price won't. This predictable pricing removes the financial anxiety of dose escalation, allowing you to focus on your results rather than unexpected cost jumps. Combined with HSA/FSA eligibility and nationwide availability without insurance, PlexusDx makes personalized semaglutide therapy accessible and transparent.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Why is my first-month weight loss smaller than I expected?
Starting doses of semaglutide are kept low to allow your body to adjust and minimize nausea or other side effects. Month one establishes your baseline response; meaningful fat loss typically accelerates during months two through four as doses increase. This gradual approach improves long-term adherence and safety.
Is 1 to 5 pounds of weight loss in month one typical on semaglutide?
Yes, clinical trials confirm that initial monthly weight loss ranges from 1 to 5 pounds depending on your starting weight, dose level, and individual metabolism. This steady early loss reflects the medication's appetite-suppressing effects, which become more pronounced as your dose increases over subsequent weeks.
How does PlexusDx semaglutide compare to Wegovy in terms of cost?
PlexusDx compounded semaglutide injections start at $149 per month—often significantly lower than brand-name Wegovy—with no membership fees, insurance required, or flat per-compound pricing increases. PlexusDx products are prepared by licensed 503A compounding pharmacies and are HSA/FSA eligible, making treatment affordable and personalized.
What causes the variation in first-month weight loss between patients?
Differences in starting weight, baseline metabolism, genetic factors, diet quality, and activity level all influence early results. Genetic variants in your GLP1R and GIPR genes directly affect how strongly your body responds to semaglutide, which is why PlexusDx offers the Precision Peptide Genetic Test to map your peptide pathways and optimize your treatment.
Can genetic testing predict my weight loss on semaglutide?
PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes 14 metabolic pathways and 49 peptides, including your GLP1R responsiveness variants, to reveal your inherited predispositions for GLP-1 effectiveness. While genetics don't determine your outcome alone, understanding your peptide pathways helps your provider personalize your dose and treatment strategy for better results.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Is Zepbound Better Than Ozempic? A Comprehensive Analysis
What to Expect After Your First Ozempic Injection